nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCB1—ovarian cancer	0.274	1	CbGaD
Apixaban—ABCG2—Topotecan—ovarian cancer	0.108	0.195	CbGbCtD
Apixaban—ABCG2—Paclitaxel—ovarian cancer	0.0536	0.0964	CbGbCtD
Apixaban—ABCG2—Carboplatin—ovarian cancer	0.0505	0.0907	CbGbCtD
Apixaban—ABCB1—Topotecan—ovarian cancer	0.039	0.0702	CbGbCtD
Apixaban—ABCG2—Docetaxel—ovarian cancer	0.0388	0.0697	CbGbCtD
Apixaban—CYP3A5—Paclitaxel—ovarian cancer	0.0297	0.0534	CbGbCtD
Apixaban—ABCG2—Doxorubicin—ovarian cancer	0.0289	0.052	CbGbCtD
Apixaban—CYP2C8—Paclitaxel—ovarian cancer	0.0286	0.0514	CbGbCtD
Apixaban—ABCB1—Vinorelbine—ovarian cancer	0.0275	0.0495	CbGbCtD
Apixaban—CYP3A4—Topotecan—ovarian cancer	0.0234	0.0421	CbGbCtD
Apixaban—CYP3A5—Docetaxel—ovarian cancer	0.0215	0.0386	CbGbCtD
Apixaban—CYP2C9—Paclitaxel—ovarian cancer	0.0199	0.0358	CbGbCtD
Apixaban—ABCB1—Paclitaxel—ovarian cancer	0.0193	0.0348	CbGbCtD
Apixaban—CYP3A4—Vinorelbine—ovarian cancer	0.0165	0.0296	CbGbCtD
Apixaban—Compartment syndrome—Melphalan—ovarian cancer	0.0157	0.148	CcSEcCtD
Apixaban—ABCB1—Docetaxel—ovarian cancer	0.014	0.0251	CbGbCtD
Apixaban—CYP3A4—Paclitaxel—ovarian cancer	0.0116	0.0208	CbGbCtD
Apixaban—ABCB1—Doxorubicin—ovarian cancer	0.0104	0.0187	CbGbCtD
Apixaban—CYP3A4—Docetaxel—ovarian cancer	0.00837	0.0151	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—ovarian cancer	0.00624	0.0112	CbGbCtD
Apixaban—Blood alkaline phosphatase increased—Altretamine—ovarian cancer	0.00305	0.0288	CcSEcCtD
Apixaban—F10—uterine cervix—ovarian cancer	0.00245	0.0638	CbGeAlD
Apixaban—F10—decidua—ovarian cancer	0.00234	0.0608	CbGeAlD
Apixaban—F10—endometrium—ovarian cancer	0.00222	0.0577	CbGeAlD
Apixaban—Transaminases increased—Melphalan—ovarian cancer	0.00186	0.0176	CcSEcCtD
Apixaban—F10—female reproductive system—ovarian cancer	0.00184	0.0478	CbGeAlD
Apixaban—CYP2J2—endometrium—ovarian cancer	0.00182	0.0473	CbGeAlD
Apixaban—CYP2J2—uterus—ovarian cancer	0.00168	0.0436	CbGeAlD
Apixaban—F10—female gonad—ovarian cancer	0.00167	0.0435	CbGeAlD
Apixaban—F10—vagina—ovarian cancer	0.00166	0.0432	CbGeAlD
Apixaban—Drug hypersensitivity—Paclitaxel—ovarian cancer	0.00165	0.0156	CcSEcCtD
Apixaban—Transaminases increased—Vinorelbine—ovarian cancer	0.00163	0.0153	CcSEcCtD
Apixaban—CYP2J2—female reproductive system—ovarian cancer	0.00151	0.0392	CbGeAlD
Apixaban—F10—testis—ovarian cancer	0.00148	0.0386	CbGeAlD
Apixaban—Anaemia—Altretamine—ovarian cancer	0.00148	0.0139	CcSEcCtD
Apixaban—CYP2J2—vagina—ovarian cancer	0.00136	0.0354	CbGeAlD
Apixaban—Thrombocytopenia—Altretamine—ovarian cancer	0.00128	0.012	CcSEcCtD
Apixaban—Blood bilirubin increased—Topotecan—ovarian cancer	0.00122	0.0115	CcSEcCtD
Apixaban—CYP2J2—testis—ovarian cancer	0.00122	0.0316	CbGeAlD
Apixaban—F10—lymph node—ovarian cancer	0.00108	0.028	CbGeAlD
Apixaban—Blood bilirubin increased—Vinorelbine—ovarian cancer	0.00105	0.00986	CcSEcCtD
Apixaban—ABCG2—myometrium—ovarian cancer	0.00098	0.0255	CbGeAlD
Apixaban—Haematochezia—Epirubicin—ovarian cancer	0.000945	0.00891	CcSEcCtD
Apixaban—Drug hypersensitivity—Epirubicin—ovarian cancer	0.000945	0.00891	CcSEcCtD
Apixaban—Haemoptysis—Paclitaxel—ovarian cancer	0.000899	0.00848	CcSEcCtD
Apixaban—Haematochezia—Doxorubicin—ovarian cancer	0.000874	0.00824	CcSEcCtD
Apixaban—Drug hypersensitivity—Doxorubicin—ovarian cancer	0.000874	0.00824	CcSEcCtD
Apixaban—Dizziness—Altretamine—ovarian cancer	0.000863	0.00813	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Paclitaxel—ovarian cancer	0.000809	0.00763	CcSEcCtD
Apixaban—Nausea—Altretamine—ovarian cancer	0.000775	0.0073	CcSEcCtD
Apixaban—Contusion—Paclitaxel—ovarian cancer	0.000763	0.00719	CcSEcCtD
Apixaban—ABCG2—uterine cervix—ovarian cancer	0.000763	0.0198	CbGeAlD
Apixaban—Liver function test abnormal—Melphalan—ovarian cancer	0.000759	0.00716	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Topotecan—ovarian cancer	0.000756	0.00713	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Topotecan—ovarian cancer	0.000741	0.00698	CcSEcCtD
Apixaban—Rectal haemorrhage—Paclitaxel—ovarian cancer	0.000737	0.00695	CcSEcCtD
Apixaban—ABCG2—decidua—ovarian cancer	0.000727	0.0189	CbGeAlD
Apixaban—CYP2C8—endometrium—ovarian cancer	0.00071	0.0184	CbGeAlD
Apixaban—CYP3A5—uterine cervix—ovarian cancer	0.000708	0.0184	CbGeAlD
Apixaban—Blood bilirubin increased—Paclitaxel—ovarian cancer	0.000704	0.00663	CcSEcCtD
Apixaban—ABCG2—endometrium—ovarian cancer	0.00069	0.0179	CbGeAlD
Apixaban—Gingival bleeding—Epirubicin—ovarian cancer	0.000671	0.00632	CcSEcCtD
Apixaban—Melaena—Paclitaxel—ovarian cancer	0.00065	0.00613	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Vinorelbine—ovarian cancer	0.000647	0.0061	CcSEcCtD
Apixaban—ABCG2—uterus—ovarian cancer	0.000636	0.0165	CbGeAlD
Apixaban—Transaminases increased—Epirubicin—ovarian cancer	0.000626	0.0059	CcSEcCtD
Apixaban—Gingival bleeding—Doxorubicin—ovarian cancer	0.000621	0.00585	CcSEcCtD
Apixaban—Hepatobiliary disease—Topotecan—ovarian cancer	0.000612	0.00577	CcSEcCtD
Apixaban—Epistaxis—Topotecan—ovarian cancer	0.00061	0.00575	CcSEcCtD
Apixaban—CYP2C19—vagina—ovarian cancer	0.000609	0.0158	CbGeAlD
Apixaban—Hepatobiliary disease—Melphalan—ovarian cancer	0.000599	0.00565	CcSEcCtD
Apixaban—Blood bilirubin increased—Docetaxel—ovarian cancer	0.000597	0.00562	CcSEcCtD
Apixaban—CYP2C8—female reproductive system—ovarian cancer	0.000588	0.0153	CbGeAlD
Apixaban—Haemoglobin—Topotecan—ovarian cancer	0.000584	0.0055	CcSEcCtD
Apixaban—Haemorrhage—Topotecan—ovarian cancer	0.000581	0.00548	CcSEcCtD
Apixaban—Transaminases increased—Doxorubicin—ovarian cancer	0.000579	0.00546	CcSEcCtD
Apixaban—Haemoglobin—Melphalan—ovarian cancer	0.000572	0.00539	CcSEcCtD
Apixaban—Haemorrhage—Melphalan—ovarian cancer	0.000569	0.00536	CcSEcCtD
Apixaban—Urinary tract disorder—Melphalan—ovarian cancer	0.000562	0.0053	CcSEcCtD
Apixaban—Connective tissue disorder—Melphalan—ovarian cancer	0.000559	0.00527	CcSEcCtD
Apixaban—Urethral disorder—Melphalan—ovarian cancer	0.000558	0.00526	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Paclitaxel—ovarian cancer	0.000556	0.00524	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—ovarian cancer	0.000548	0.00516	CcSEcCtD
Apixaban—ABCG2—bone marrow—ovarian cancer	0.00054	0.014	CbGeAlD
Apixaban—CYP2C8—vagina—ovarian cancer	0.000532	0.0138	CbGeAlD
Apixaban—Angiopathy—Topotecan—ovarian cancer	0.000527	0.00497	CcSEcCtD
Apixaban—Anaemia—Chlorambucil—ovarian cancer	0.000525	0.00495	CcSEcCtD
Apixaban—Immune system disorder—Topotecan—ovarian cancer	0.000525	0.00495	CcSEcCtD
Apixaban—Mediastinal disorder—Topotecan—ovarian cancer	0.000524	0.00494	CcSEcCtD
Apixaban—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.000524	0.00494	CcSEcCtD
Apixaban—CYP2C9—female reproductive system—ovarian cancer	0.000522	0.0136	CbGeAlD
Apixaban—ABCG2—female gonad—ovarian cancer	0.00052	0.0135	CbGeAlD
Apixaban—ABCG2—vagina—ovarian cancer	0.000517	0.0134	CbGeAlD
Apixaban—Haemoptysis—Epirubicin—ovarian cancer	0.000514	0.00485	CcSEcCtD
Apixaban—Vaginal haemorrhage—Epirubicin—ovarian cancer	0.000514	0.00485	CcSEcCtD
Apixaban—Immune system disorder—Melphalan—ovarian cancer	0.000514	0.00484	CcSEcCtD
Apixaban—Mediastinal disorder—Melphalan—ovarian cancer	0.000513	0.00483	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—ovarian cancer	0.000507	0.00478	CcSEcCtD
Apixaban—Connective tissue disorder—Vinorelbine—ovarian cancer	0.000488	0.0046	CcSEcCtD
Apixaban—ABCB1—myometrium—ovarian cancer	0.000483	0.0126	CbGeAlD
Apixaban—CYP3A5—female gonad—ovarian cancer	0.000483	0.0125	CbGeAlD
Apixaban—CYP3A5—vagina—ovarian cancer	0.00048	0.0125	CbGeAlD
Apixaban—Haemoptysis—Doxorubicin—ovarian cancer	0.000476	0.00448	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—ovarian cancer	0.000476	0.00448	CcSEcCtD
Apixaban—CYP2C8—testis—ovarian cancer	0.000474	0.0123	CbGeAlD
Apixaban—Blood alkaline phosphatase increased—Docetaxel—ovarian cancer	0.000471	0.00444	CcSEcCtD
Apixaban—Anaemia—Topotecan—ovarian cancer	0.000467	0.00441	CcSEcCtD
Apixaban—ABCB1—embryo—ovarian cancer	0.000465	0.0121	CbGeAlD
Apixaban—Petechiae—Epirubicin—ovarian cancer	0.000463	0.00436	CcSEcCtD
Apixaban—ABCG2—testis—ovarian cancer	0.000461	0.012	CbGeAlD
Apixaban—Anaemia—Melphalan—ovarian cancer	0.000458	0.00431	CcSEcCtD
Apixaban—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000454	0.00428	CcSEcCtD
Apixaban—Angiopathy—Vinorelbine—ovarian cancer	0.000451	0.00425	CcSEcCtD
Apixaban—Immune system disorder—Vinorelbine—ovarian cancer	0.000449	0.00423	CcSEcCtD
Apixaban—Mediastinal disorder—Vinorelbine—ovarian cancer	0.000448	0.00422	CcSEcCtD
Apixaban—Liver function test abnormal—Paclitaxel—ovarian cancer	0.000446	0.00421	CcSEcCtD
Apixaban—Breast disorder—Paclitaxel—ovarian cancer	0.000437	0.00412	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.000435	0.0041	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—ovarian cancer	0.000428	0.00403	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000428	0.00403	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.000426	0.00402	CcSEcCtD
Apixaban—Rectal haemorrhage—Epirubicin—ovarian cancer	0.000421	0.00397	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000419	0.00395	CcSEcCtD
Apixaban—Anaphylactic shock—Topotecan—ovarian cancer	0.000413	0.00389	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00041	0.00386	CcSEcCtD
Apixaban—Nervous system disorder—Topotecan—ovarian cancer	0.000405	0.00382	CcSEcCtD
Apixaban—Anaphylactic shock—Melphalan—ovarian cancer	0.000404	0.00381	CcSEcCtD
Apixaban—Thrombocytopenia—Topotecan—ovarian cancer	0.000404	0.00381	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—ovarian cancer	0.000402	0.00379	CcSEcCtD
Apixaban—Skin disorder—Topotecan—ovarian cancer	0.000401	0.00378	CcSEcCtD
Apixaban—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.0004	0.00377	CcSEcCtD
Apixaban—Anaemia—Vinorelbine—ovarian cancer	0.0004	0.00377	CcSEcCtD
Apixaban—CYP3A4—female reproductive system—ovarian cancer	0.000398	0.0103	CbGeAlD
Apixaban—Thrombocytopenia—Melphalan—ovarian cancer	0.000396	0.00373	CcSEcCtD
Apixaban—Skin disorder—Melphalan—ovarian cancer	0.000393	0.0037	CcSEcCtD
Apixaban—Rectal haemorrhage—Doxorubicin—ovarian cancer	0.00039	0.00368	CcSEcCtD
Apixaban—ABCB1—epithelium—ovarian cancer	0.000379	0.00986	CbGeAlD
Apixaban—Liver function test abnormal—Docetaxel—ovarian cancer	0.000378	0.00356	CcSEcCtD
Apixaban—Hypotension—Melphalan—ovarian cancer	0.000378	0.00356	CcSEcCtD
Apixaban—ABCB1—uterine cervix—ovarian cancer	0.000376	0.00977	CbGeAlD
Apixaban—Blood bilirubin increased—Doxorubicin—ovarian cancer	0.000372	0.00351	CcSEcCtD
Apixaban—Melaena—Epirubicin—ovarian cancer	0.000372	0.0035	CcSEcCtD
Apixaban—Breast disorder—Docetaxel—ovarian cancer	0.00037	0.00349	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000369	0.00348	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000366	0.00345	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000361	0.00341	CcSEcCtD
Apixaban—ABCB1—decidua—ovarian cancer	0.000358	0.00931	CbGeAlD
Apixaban—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000356	0.00336	CcSEcCtD
Apixaban—Haematuria—Paclitaxel—ovarian cancer	0.000355	0.00335	CcSEcCtD
Apixaban—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000353	0.00333	CcSEcCtD
Apixaban—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000352	0.00332	CcSEcCtD
Apixaban—Epistaxis—Paclitaxel—ovarian cancer	0.000351	0.00331	CcSEcCtD
Apixaban—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000349	0.00329	CcSEcCtD
Apixaban—Nervous system disorder—Vinorelbine—ovarian cancer	0.000346	0.00326	CcSEcCtD
Apixaban—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000346	0.00326	CcSEcCtD
Apixaban—Ecchymosis—Epirubicin—ovarian cancer	0.000344	0.00324	CcSEcCtD
Apixaban—Melaena—Doxorubicin—ovarian cancer	0.000344	0.00324	CcSEcCtD
Apixaban—Skin disorder—Vinorelbine—ovarian cancer	0.000343	0.00323	CcSEcCtD
Apixaban—Hypersensitivity—Chlorambucil—ovarian cancer	0.000342	0.00322	CcSEcCtD
Apixaban—ABCB1—endometrium—ovarian cancer	0.00034	0.00884	CbGeAlD
Apixaban—Haemoglobin—Paclitaxel—ovarian cancer	0.000336	0.00317	CcSEcCtD
Apixaban—ABCG2—lymph node—ovarian cancer	0.000334	0.00869	CbGeAlD
Apixaban—Haemorrhage—Paclitaxel—ovarian cancer	0.000334	0.00315	CcSEcCtD
Apixaban—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00033	0.00311	CcSEcCtD
Apixaban—Hypotension—Vinorelbine—ovarian cancer	0.00033	0.00311	CcSEcCtD
Apixaban—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000328	0.0031	CcSEcCtD
Apixaban—Urethral disorder—Paclitaxel—ovarian cancer	0.000328	0.00309	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—ovarian cancer	0.000318	0.003	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.000318	0.00299	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—ovarian cancer	0.000318	0.00299	CcSEcCtD
Apixaban—ABCB1—gonad—ovarian cancer	0.000316	0.0082	CbGeAlD
Apixaban—ABCB1—uterus—ovarian cancer	0.000313	0.00814	CbGeAlD
Apixaban—Eye disorder—Paclitaxel—ovarian cancer	0.000312	0.00294	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000305	0.00287	CcSEcCtD
Apixaban—Hypersensitivity—Topotecan—ovarian cancer	0.000304	0.00287	CcSEcCtD
Apixaban—Angiopathy—Paclitaxel—ovarian cancer	0.000303	0.00286	CcSEcCtD
Apixaban—Immune system disorder—Paclitaxel—ovarian cancer	0.000302	0.00285	CcSEcCtD
Apixaban—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000301	0.00284	CcSEcCtD
Apixaban—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000299	0.00281	CcSEcCtD
Apixaban—Hypersensitivity—Melphalan—ovarian cancer	0.000298	0.00281	CcSEcCtD
Apixaban—Epistaxis—Docetaxel—ovarian cancer	0.000298	0.00281	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000294	0.00277	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000294	0.00277	CcSEcCtD
Apixaban—Haemoglobin—Docetaxel—ovarian cancer	0.000285	0.00268	CcSEcCtD
Apixaban—Haemorrhage—Docetaxel—ovarian cancer	0.000283	0.00267	CcSEcCtD
Apixaban—ABCB1—female reproductive system—ovarian cancer	0.000282	0.00732	CbGeAlD
Apixaban—Urinary tract disorder—Docetaxel—ovarian cancer	0.00028	0.00264	CcSEcCtD
Apixaban—Connective tissue disorder—Docetaxel—ovarian cancer	0.000278	0.00262	CcSEcCtD
Apixaban—Urethral disorder—Docetaxel—ovarian cancer	0.000278	0.00262	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000276	0.0026	CcSEcCtD
Apixaban—Nausea—Chlorambucil—ovarian cancer	0.000275	0.0026	CcSEcCtD
Apixaban—Dizziness—Topotecan—ovarian cancer	0.000273	0.00257	CcSEcCtD
Apixaban—Anaemia—Paclitaxel—ovarian cancer	0.000269	0.00254	CcSEcCtD
Apixaban—ABCB1—bone marrow—ovarian cancer	0.000266	0.00691	CbGeAlD
Apixaban—Eye disorder—Docetaxel—ovarian cancer	0.000265	0.0025	CcSEcCtD
Apixaban—Syncope—Paclitaxel—ovarian cancer	0.000261	0.00246	CcSEcCtD
Apixaban—Rash—Topotecan—ovarian cancer	0.00026	0.00245	CcSEcCtD
Apixaban—Hypersensitivity—Vinorelbine—ovarian cancer	0.00026	0.00245	CcSEcCtD
Apixaban—Dermatitis—Topotecan—ovarian cancer	0.00026	0.00245	CcSEcCtD
Apixaban—Angiopathy—Docetaxel—ovarian cancer	0.000257	0.00242	CcSEcCtD
Apixaban—ABCB1—female gonad—ovarian cancer	0.000256	0.00666	CbGeAlD
Apixaban—Immune system disorder—Docetaxel—ovarian cancer	0.000256	0.00241	CcSEcCtD
Apixaban—Loss of consciousness—Paclitaxel—ovarian cancer	0.000256	0.00241	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000256	0.00241	CcSEcCtD
Apixaban—Mediastinal disorder—Docetaxel—ovarian cancer	0.000255	0.00241	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—ovarian cancer	0.000255	0.0024	CcSEcCtD
Apixaban—ABCB1—vagina—ovarian cancer	0.000255	0.00662	CbGeAlD
Apixaban—Rash—Melphalan—ovarian cancer	0.000255	0.0024	CcSEcCtD
Apixaban—Dermatitis—Melphalan—ovarian cancer	0.000255	0.0024	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—ovarian cancer	0.00025	0.00235	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000249	0.00235	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000246	0.00232	CcSEcCtD
Apixaban—Nausea—Topotecan—ovarian cancer	0.000245	0.00231	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000244	0.0023	CcSEcCtD
Apixaban—Nausea—Melphalan—ovarian cancer	0.00024	0.00226	CcSEcCtD
Apixaban—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000237	0.00224	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000236	0.00222	CcSEcCtD
Apixaban—Shock—Paclitaxel—ovarian cancer	0.000234	0.0022	CcSEcCtD
Apixaban—Dizziness—Vinorelbine—ovarian cancer	0.000233	0.0022	CcSEcCtD
Apixaban—Nervous system disorder—Paclitaxel—ovarian cancer	0.000233	0.0022	CcSEcCtD
Apixaban—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000233	0.00219	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—ovarian cancer	0.000231	0.00218	CcSEcCtD
Apixaban—Skin disorder—Paclitaxel—ovarian cancer	0.000231	0.00217	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00023	0.00217	CcSEcCtD
Apixaban—Anaemia—Docetaxel—ovarian cancer	0.000228	0.00215	CcSEcCtD
Apixaban—ABCB1—testis—ovarian cancer	0.000227	0.00591	CbGeAlD
Apixaban—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000225	0.00213	CcSEcCtD
Apixaban—Rash—Vinorelbine—ovarian cancer	0.000223	0.0021	CcSEcCtD
Apixaban—Dermatitis—Vinorelbine—ovarian cancer	0.000222	0.0021	CcSEcCtD
Apixaban—Hypotension—Paclitaxel—ovarian cancer	0.000222	0.00209	CcSEcCtD
Apixaban—Syncope—Docetaxel—ovarian cancer	0.000221	0.00209	CcSEcCtD
Apixaban—Loss of consciousness—Docetaxel—ovarian cancer	0.000217	0.00204	CcSEcCtD
Apixaban—Nausea—Vinorelbine—ovarian cancer	0.00021	0.00198	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000209	0.00197	CcSEcCtD
Apixaban—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000205	0.00193	CcSEcCtD
Apixaban—Haematuria—Epirubicin—ovarian cancer	0.000203	0.00191	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000201	0.0019	CcSEcCtD
Apixaban—Anaphylactic shock—Docetaxel—ovarian cancer	0.000201	0.0019	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—ovarian cancer	0.000201	0.00189	CcSEcCtD
Apixaban—Shock—Docetaxel—ovarian cancer	0.000198	0.00187	CcSEcCtD
Apixaban—Nervous system disorder—Docetaxel—ovarian cancer	0.000197	0.00186	CcSEcCtD
Apixaban—Thrombocytopenia—Docetaxel—ovarian cancer	0.000197	0.00186	CcSEcCtD
Apixaban—Skin disorder—Docetaxel—ovarian cancer	0.000196	0.00184	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—ovarian cancer	0.000192	0.00181	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—ovarian cancer	0.000191	0.0018	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—ovarian cancer	0.000189	0.00178	CcSEcCtD
Apixaban—Hypotension—Docetaxel—ovarian cancer	0.000188	0.00177	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—ovarian cancer	0.000188	0.00177	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—ovarian cancer	0.000188	0.00177	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—ovarian cancer	0.000187	0.00177	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000186	0.00176	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—ovarian cancer	0.000186	0.00175	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—ovarian cancer	0.000179	0.00168	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—ovarian cancer	0.000178	0.00168	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—ovarian cancer	0.000177	0.00167	CcSEcCtD
Apixaban—Hypersensitivity—Paclitaxel—ovarian cancer	0.000175	0.00165	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000175	0.00165	CcSEcCtD
Apixaban—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000174	0.00164	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000174	0.00164	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—ovarian cancer	0.000173	0.00163	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—ovarian cancer	0.000173	0.00163	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—ovarian cancer	0.000173	0.00163	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—ovarian cancer	0.000172	0.00162	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—ovarian cancer	0.000165	0.00156	CcSEcCtD
Apixaban—ABCB1—lymph node—ovarian cancer	0.000165	0.00428	CbGeAlD
Apixaban—Angiopathy—Doxorubicin—ovarian cancer	0.00016	0.00151	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—ovarian cancer	0.00016	0.00151	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000159	0.0015	CcSEcCtD
Apixaban—Dizziness—Paclitaxel—ovarian cancer	0.000157	0.00148	CcSEcCtD
Apixaban—Anaemia—Epirubicin—ovarian cancer	0.000154	0.00145	CcSEcCtD
Apixaban—Rash—Paclitaxel—ovarian cancer	0.00015	0.00141	CcSEcCtD
Apixaban—Dermatitis—Paclitaxel—ovarian cancer	0.00015	0.00141	CcSEcCtD
Apixaban—Syncope—Epirubicin—ovarian cancer	0.000149	0.00141	CcSEcCtD
Apixaban—Hypersensitivity—Docetaxel—ovarian cancer	0.000148	0.0014	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—ovarian cancer	0.000146	0.00138	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—ovarian cancer	0.000142	0.00134	CcSEcCtD
Apixaban—Nausea—Paclitaxel—ovarian cancer	0.000141	0.00133	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000141	0.00133	CcSEcCtD
Apixaban—Syncope—Doxorubicin—ovarian cancer	0.000138	0.0013	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—ovarian cancer	0.000136	0.00128	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—ovarian cancer	0.000135	0.00128	CcSEcCtD
Apixaban—Shock—Epirubicin—ovarian cancer	0.000134	0.00126	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—ovarian cancer	0.000133	0.00126	CcSEcCtD
Apixaban—Dizziness—Docetaxel—ovarian cancer	0.000133	0.00125	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—ovarian cancer	0.000133	0.00125	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—ovarian cancer	0.000132	0.00124	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00013	0.00123	CcSEcCtD
Apixaban—Rash—Docetaxel—ovarian cancer	0.000127	0.0012	CcSEcCtD
Apixaban—Hypotension—Epirubicin—ovarian cancer	0.000127	0.0012	CcSEcCtD
Apixaban—Dermatitis—Docetaxel—ovarian cancer	0.000127	0.0012	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000126	0.00118	CcSEcCtD
Apixaban—Shock—Doxorubicin—ovarian cancer	0.000124	0.00117	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—ovarian cancer	0.000123	0.00116	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000123	0.00116	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—ovarian cancer	0.000122	0.00115	CcSEcCtD
Apixaban—Nausea—Docetaxel—ovarian cancer	0.00012	0.00113	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—ovarian cancer	0.000117	0.00111	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000117	0.00111	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000108	0.00102	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—ovarian cancer	0.0001	0.000943	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—ovarian cancer	9.26e-05	0.000873	CcSEcCtD
Apixaban—Dizziness—Epirubicin—ovarian cancer	8.98e-05	0.000846	CcSEcCtD
Apixaban—Rash—Epirubicin—ovarian cancer	8.56e-05	0.000807	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—ovarian cancer	8.55e-05	0.000806	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—ovarian cancer	8.31e-05	0.000783	CcSEcCtD
Apixaban—Nausea—Epirubicin—ovarian cancer	8.07e-05	0.00076	CcSEcCtD
Apixaban—Rash—Doxorubicin—ovarian cancer	7.92e-05	0.000747	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—ovarian cancer	7.91e-05	0.000746	CcSEcCtD
Apixaban—Nausea—Doxorubicin—ovarian cancer	7.46e-05	0.000703	CcSEcCtD
Apixaban—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.95e-05	0.00116	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CASP3—ovarian cancer	2.95e-05	0.00116	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL2—ovarian cancer	2.94e-05	0.00116	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.89e-05	0.00114	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.86e-05	0.00113	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.83e-05	0.00112	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.82e-05	0.00112	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.81e-05	0.00111	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.77e-05	0.00109	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.77e-05	0.00109	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.77e-05	0.00109	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.76e-05	0.00109	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYTB—ovarian cancer	2.75e-05	0.00108	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.72e-05	0.00108	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.66e-05	0.00105	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NME2—ovarian cancer	2.64e-05	0.00104	CbGpPWpGaD
Apixaban—F10—Hemostasis—VEGFA—ovarian cancer	2.64e-05	0.00104	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PPP2R1A—ovarian cancer	2.63e-05	0.00104	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.62e-05	0.00104	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.61e-05	0.00103	CbGpPWpGaD
Apixaban—F10—Hemostasis—NRAS—ovarian cancer	2.61e-05	0.00103	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CXCL8—ovarian cancer	2.56e-05	0.00101	CbGpPWpGaD
Apixaban—F10—Hemostasis—MAPK3—ovarian cancer	2.5e-05	0.000987	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.5e-05	0.000987	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ABCB1—ovarian cancer	2.45e-05	0.000966	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—TYMS—ovarian cancer	2.4e-05	0.000949	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPP1CC—ovarian cancer	2.4e-05	0.000948	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—BRIP1—ovarian cancer	2.4e-05	0.000948	CbGpPWpGaD
Apixaban—F10—Hemostasis—MAPK1—ovarian cancer	2.38e-05	0.00094	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CTNNB1—ovarian cancer	2.36e-05	0.000933	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NME2—ovarian cancer	2.36e-05	0.000932	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.33e-05	0.000919	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.33e-05	0.000919	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NME2—ovarian cancer	2.3e-05	0.00091	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.3e-05	0.000907	CbGpPWpGaD
Apixaban—F10—Hemostasis—KRAS—ovarian cancer	2.25e-05	0.000887	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.24e-05	0.000886	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.23e-05	0.000882	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.22e-05	0.000878	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.18e-05	0.000862	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NME2—ovarian cancer	2.15e-05	0.00085	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.1e-05	0.00083	CbGpPWpGaD
Apixaban—F10—Hemostasis—PIK3CA—ovarian cancer	2.06e-05	0.000815	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.06e-05	0.000815	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2e-05	0.000791	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—ovarian cancer	2e-05	0.000789	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYTB—ovarian cancer	1.97e-05	0.000777	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CAV1—ovarian cancer	1.94e-05	0.000765	CbGpPWpGaD
Apixaban—F10—Hemostasis—HRAS—ovarian cancer	1.91e-05	0.000754	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.85e-05	0.000731	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.84e-05	0.000727	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NME2—ovarian cancer	1.84e-05	0.000726	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.83e-05	0.000722	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.83e-05	0.000721	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CG—ovarian cancer	1.76e-05	0.000697	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.72e-05	0.000679	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.72e-05	0.000679	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYTB—ovarian cancer	1.7e-05	0.000673	CbGpPWpGaD
Apixaban—F10—Hemostasis—AKT1—ovarian cancer	1.69e-05	0.000666	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.67e-05	0.000658	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.63e-05	0.000645	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—YAP1—ovarian cancer	1.61e-05	0.000636	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.6e-05	0.000633	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.56e-05	0.000616	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CD—ovarian cancer	1.55e-05	0.000612	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYTB—ovarian cancer	1.52e-05	0.000601	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.49e-05	0.000589	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.49e-05	0.000588	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.49e-05	0.000588	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.49e-05	0.000588	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.49e-05	0.000587	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYTB—ovarian cancer	1.48e-05	0.000586	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.48e-05	0.000586	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.45e-05	0.000574	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.44e-05	0.000568	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NME2—ovarian cancer	1.42e-05	0.000561	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.41e-05	0.000559	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.4e-05	0.000553	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYTB—ovarian cancer	1.39e-05	0.000548	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.37e-05	0.000539	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.36e-05	0.000535	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CB—ovarian cancer	1.35e-05	0.000534	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.33e-05	0.000525	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.33e-05	0.000525	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—FASN—ovarian cancer	1.31e-05	0.000518	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—BRIP1—ovarian cancer	1.3e-05	0.000513	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.3e-05	0.000513	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.29e-05	0.00051	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.27e-05	0.000502	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.25e-05	0.000492	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.23e-05	0.000487	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.21e-05	0.000479	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.21e-05	0.000479	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.19e-05	0.000472	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYTB—ovarian cancer	1.18e-05	0.000468	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTEN—ovarian cancer	1.17e-05	0.000461	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.17e-05	0.000461	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.16e-05	0.000458	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—YAP1—ovarian cancer	1.15e-05	0.000456	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.13e-05	0.000448	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.11e-05	0.000439	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.11e-05	0.000438	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.09e-05	0.000429	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.06e-05	0.000419	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.05e-05	0.000414	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.04e-05	0.000409	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.04e-05	0.000409	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—YAP1—ovarian cancer	9.99e-06	0.000395	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.88e-06	0.00039	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ABCB1—ovarian cancer	9.84e-06	0.000389	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.69e-06	0.000383	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—TYMS—ovarian cancer	9.66e-06	0.000382	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.63e-06	0.000381	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—FASN—ovarian cancer	9.4e-06	0.000371	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.32e-06	0.000368	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SLC5A5—ovarian cancer	9.25e-06	0.000365	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYTB—ovarian cancer	9.14e-06	0.000361	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SLC2A1—ovarian cancer	8.93e-06	0.000353	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—YAP1—ovarian cancer	8.91e-06	0.000352	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.83e-06	0.000349	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.82e-06	0.000349	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—YAP1—ovarian cancer	8.7e-06	0.000344	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.69e-06	0.000343	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1B1—ovarian cancer	8.56e-06	0.000338	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—ovarian cancer	8.24e-06	0.000325	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—FASN—ovarian cancer	8.14e-06	0.000322	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—YAP1—ovarian cancer	8.13e-06	0.000321	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.04e-06	0.000318	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC5A5—ovarian cancer	8.01e-06	0.000316	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.99e-06	0.000316	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.99e-06	0.000316	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.87e-06	0.000311	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CAV1—ovarian cancer	7.79e-06	0.000308	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.76e-06	0.000306	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SLC2A1—ovarian cancer	7.73e-06	0.000306	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	7.59e-06	0.0003	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.57e-06	0.000299	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.55e-06	0.000298	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1B1—ovarian cancer	7.42e-06	0.000293	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—FASN—ovarian cancer	7.27e-06	0.000287	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC5A5—ovarian cancer	7.15e-06	0.000282	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—FASN—ovarian cancer	7.09e-06	0.00028	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CG—ovarian cancer	7.09e-06	0.00028	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.07e-06	0.000279	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCB1—ovarian cancer	7.05e-06	0.000279	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.98e-06	0.000276	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—YAP1—ovarian cancer	6.95e-06	0.000274	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TYMS—ovarian cancer	6.92e-06	0.000274	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.9e-06	0.000273	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.87e-06	0.000272	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.76e-06	0.000267	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.74e-06	0.000266	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—ovarian cancer	6.73e-06	0.000266	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—FASN—ovarian cancer	6.63e-06	0.000262	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.62e-06	0.000261	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	6.58e-06	0.00026	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.54e-06	0.000259	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.52e-06	0.000258	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.46e-06	0.000255	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.3e-06	0.000249	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CD—ovarian cancer	6.24e-06	0.000246	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.16e-06	0.000244	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—ovarian cancer	6.11e-06	0.000241	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.04e-06	0.000239	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.04e-06	0.000238	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TYMS—ovarian cancer	6e-06	0.000237	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.87e-06	0.000232	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.84e-06	0.000231	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.73e-06	0.000226	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—FASN—ovarian cancer	5.66e-06	0.000224	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CAV1—ovarian cancer	5.58e-06	0.00022	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC5A5—ovarian cancer	5.57e-06	0.00022	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.45e-06	0.000215	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.44e-06	0.000215	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC2A1—ovarian cancer	5.38e-06	0.000213	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—YAP1—ovarian cancer	5.36e-06	0.000212	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TYMS—ovarian cancer	5.35e-06	0.000211	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.35e-06	0.000211	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.33e-06	0.00021	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.27e-06	0.000208	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TYMS—ovarian cancer	5.22e-06	0.000206	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1B1—ovarian cancer	5.16e-06	0.000204	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CG—ovarian cancer	5.08e-06	0.000201	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.97e-06	0.000196	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TYMS—ovarian cancer	4.88e-06	0.000193	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAV1—ovarian cancer	4.83e-06	0.000191	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTEN—ovarian cancer	4.7e-06	0.000186	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.62e-06	0.000182	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.57e-06	0.000181	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.55e-06	0.00018	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CD—ovarian cancer	4.47e-06	0.000177	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.4e-06	0.000174	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FASN—ovarian cancer	4.37e-06	0.000173	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAV1—ovarian cancer	4.31e-06	0.00017	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.3e-06	0.00017	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—ovarian cancer	4.25e-06	0.000168	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAV1—ovarian cancer	4.21e-06	0.000166	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TYMS—ovarian cancer	4.17e-06	0.000165	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.15e-06	0.000164	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.12e-06	0.000163	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.98e-06	0.000157	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAV1—ovarian cancer	3.93e-06	0.000155	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.93e-06	0.000155	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.89e-06	0.000154	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.87e-06	0.000153	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.84e-06	0.000152	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.76e-06	0.000148	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.58e-06	0.000142	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.53e-06	0.000139	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.45e-06	0.000136	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.37e-06	0.000133	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.37e-06	0.000133	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTEN—ovarian cancer	3.37e-06	0.000133	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAV1—ovarian cancer	3.36e-06	0.000133	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.31e-06	0.000131	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.28e-06	0.000129	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TYMS—ovarian cancer	3.22e-06	0.000127	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.21e-06	0.000127	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.15e-06	0.000124	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.06e-06	0.000121	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.01e-06	0.000119	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.94e-06	0.000116	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTEN—ovarian cancer	2.91e-06	0.000115	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.75e-06	0.000108	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—ovarian cancer	2.71e-06	0.000107	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.69e-06	0.000106	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTEN—ovarian cancer	2.6e-06	0.000103	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAV1—ovarian cancer	2.59e-06	0.000102	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTEN—ovarian cancer	2.54e-06	0.0001	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.37e-06	9.38e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTEN—ovarian cancer	2.37e-06	9.37e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.36e-06	9.33e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.35e-06	9.27e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.08e-06	8.21e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.06e-06	8.12e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTEN—ovarian cancer	2.03e-06	8.01e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—ovarian cancer	1.94e-06	7.66e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.84e-06	7.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.81e-06	7.15e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.79e-06	7.08e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—ovarian cancer	1.68e-06	6.64e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.67e-06	6.61e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTEN—ovarian cancer	1.56e-06	6.18e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—ovarian cancer	1.5e-06	5.92e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—ovarian cancer	1.46e-06	5.78e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.43e-06	5.65e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—ovarian cancer	1.37e-06	5.4e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—ovarian cancer	1.17e-06	4.62e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.1e-06	4.36e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—ovarian cancer	9.02e-07	3.56e-05	CbGpPWpGaD
